REGISTER NOW
SUBMIT ABSTRACT
SCIENTIFIC AGENDA
7th World Cancer Congress - 2022 | Bangalore 8th World Cancer Congress - 2024 | New Delhi 7th World Cancer Congress - 2022 | Bangalore
Registration Window will closes soon, 2nd Phase Abstract Submission has been Extended till: 27th January, 2024
7th World Cancer Congress - 2022 | Bangalore

INVITATION TO 8TH WORLD CANCER CONGRESS - 2024

Arjyopa Healthcare and Cancer Healer Center welcomes you to attend the 8th World Cancer Congress - 2024 during March 18th - 20th, 2024 at JNU Convention Centre, Jawaharlal Nehru University, New Delhi, India. We cordially invite all the participants interested in sharing their knowledge and research in the arena of Oncology and Cancer Research. From feedback received, the previous Congresses 2016, 2017, 2018, 2019, 2020, 2021, 2022 resulted in fruitful collaborations and rewarding experiences for the delegates who left the events with concrete tools and solutions that helped them enhance their work practice and impact. As hosts, we already feel very excited to create the same energetic and inspiring atmosphere during the Congress week, adding local flavors and new perspectives such as the role of complementary treatment in cancer to the programme.

The 8th World Cancer Congress - 2024 will also explore the new ideas and concepts on global scale and the topics on Cancer Biology & Genetics, Yoga and Naturopathy, Ayurveda and Cancer, Organ-Defined Cancers, Oncology: Sub-Specialities, Radiation Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects. The 8th World Cancer Congress – 2024 will also focus on Cancer Stem Cells, Cancer Basic & Applied Research Tumor, Anti Cancer Drug Discovery, Clinical Oncology and Personalized Cancer Medicine. It will give us novel insight into the complexity of the connections between Cancer and Metabolism &Immune Checkpoints, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects, to deliver an outstanding program with the right balance of clinical relevance, which covers the entire spectrum of practice issues in Cancer Research and Treatments.

Thus, the urgent need to mobilize our efforts, promote cancer advocacy more efficiently and develop effective national policies and plans for prevention, early detection, care and support.

We look forward to the honor of welcoming you at New Delhi during the conference.


LETTER FROM THE MINISTRY


CHAIRMAN MESSAGE

On behalf of the Organizing Committee, it is my pleasure to invite all of the great scientists, academicians, young researchers, Business delegates and students from all over the world to attend the 8th World Cancer Congress – 2024 which has been scheduled from March 18th – 20th, 2024. The 8th World Cancer Congress – 2024 will be hosted at JNU Convention Centre, Jawaharlal Nehru University, New Delhi, India.

Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. This year the world cancer congress - 2024 will also focused on swadashi treatment on cancer like AYURVEDA, Homeopathy Approach towards cancer treatment, Yoga and Naturopathy, UNANI medicine etc.

WCC2024 will be the best platform for all the Oncologists, Hematologists, Ayush Practioner, Cancer Researcher, Research scholars, Students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.

We look forward to the honor of welcoming you at the summit.



With Warm Regards

Padma Shri Dr. Kodaganur S. Gopinath

Consultant Surgical Oncologist & Director

HCG, India

8th World Cancer Congress - 2024 | New Delhi


KEYNOTE SPEAKERS & FACULTY

Padma Bhushan Dr. Suresh H Advani

Senior Oncologist,

Jaslok Hospital, INDIA

Padma Bhushan Dr. G P Talwar

Former Director,

National Institute of Immunology, INDIA

Padma Shri Dr. Anil D'Cruz

Director, Oncology,

Apollo Hospital, INDIA

Padma Shri Dr. Lalit Kumar

Prof & HOD, Dept of Medical Oncology,

AIIMS, INDIA

Padma Shri Dr. Ashok Gupta

Senior Plastic Surgeon,

BHIMS, INDIA

Dr. G. K. Rath

Chief-Radiation Oncologist,

AIIMS, INDIA

Padma Shri Dr. Ramakant K. Deshpande

Senior Oncologist & Director,

Asian Cancer Institute, INDIA

Padma Shri Dr. Kamini Rao

Senior Gynaec-Oncologist,

MILANN, INDIA

Padma Shri Dr. J. K. Singh

Senior Oncologist & Director,

SS Hospitals and Research Centre, INDIA

Dr. Sanjay Sharma

Director & Senior Oncologist,

ACI-Cumballa Hill Hospital, INDIA

Dr. Raghavendra Rao

Director-CCRYN,

Ministry of AYUSH, INDIA

Dr. Tarang Krishna

Director,

Cancer Healer Center, INDIA

Dr. Deepika Krishna

Director,

Cancer Healer Center, INDIA

Dr. Shyam Aggarwal

Senior Medical Oncologist,

Sir Ganga Ram Hospital, INDIA

Dr. Ashish Kumar

Professor & Senior Consultant,

Sir Ganga Ram Hospital, INDIA

Dr. Ashok Sharma

Additional Professor,

AIIMS/NCI-Jhajjar, INDIA

Dr. Birandra K Sinha

Senior Scientist,

NIH, USA

Prof. Debu Tripathi

Dept. of Breast Medical Oncology

MD Anderson Cancer Center, USA,

Dr. Shreyash Kumar Patel

Dept. of Sarcoma Medical Oncology,

MD Anderson Cancer Center, USA

Prof. Umesh K Reddy

Dept. of Genetics & Genomics,

West Virginia State University, USA

Prof. Ashutosh Tewari

Dept. of Urology,

Icahn School of Medicine, USA

Dr. Jagadananda Ghosh

Senior Cancer Researcher,

Henry Ford Health, USA

Dr. Sikander Ailawadhi

Professor, Dept. of Oncology,

MAYO Clinic, USA

Dr. Philip Agop Philip

Professor, Dept of Oncology and Pharmacology

Wayne State University, USA

Prof. Raghu Sinha

Dept of Biochemistry and Molecular Biology,

Penn State Cancer Institute, USA

Dr. Sandip Saha

Department of Medicine,

Jacobs School of Medicine & Biomedical Sciences, USA

Dr. Hari K Koul

Professor, Dept. of Urology and Cancer Center

LSU-LCMC Cancer Center, USA

Prof. Shailesh Singh

Professor, Dept. of Microbiology, Biochemistry & Immunology

Morehouse School of Medicine, USA

Prof. Hem D. Shukla

Dept. of Radiation Oncology,

University of Maryland, USA

Prof. Arvind Rao

Department of Computational Medicine & Bioinformatics

University of Michigan, USA

Prof. Jamboor K. Vishwanatha

Regents Professor and Vice President,

University of North Texas Health Science Center, USA

Prof. Sushanta Banerjee

Dept. of Pathology and Lab Medicine,

University of Kansas Medical Center, USA

Dr. Asfar Sohail Azmi

Associate Professor, Department of Oncology,

Wayne State University, USA

Prof. Ravinder Mamtani

Vice Dean, Population Health and Lifestyle Medicine,

Weill Cornell Medicine,Qatar

Prof. Pradeep Tyagi

Associate Professor, Department of Urology,

University of Pittsburgh, USA

Dr. A K Dewan

Director, Dept. of Surgical Oncology,

Rajiv Gandhi Cancer Institute and Research Centre, INDIA

Prof. Pankaj Kumar Singh

Prof. and Founding Chairman, Dept. of Oncology Science,

OUH Stephenson Cancer Center, USA

Prof. Manjeet K. Rao

Deputy Director, Greehey Children’s Cancer Research Institute

UT Health San Antonio, USA

Prof. Rajagopal Ramesh

Professor and Associate Director, Dept of Pathology

OU College of Medicine, USA

Dr. Swarupa Mitra

Director and Unit Head, Dept. of Radiation Oncology,

FMRI, INDIA

Prof. Rajvir Dahiya

Professor, Dept. of Uro-Oncology,

UCSF, USA

Prof. Keshav K Singh

Professor, Dept of Genetic Research,

The University of Alabama, USA

Prof. Lavanya Vishwanatha

Research Enterprise Solutions Director,

UNTHSC, USA

Dr. Rasleen K. Saluja

Department of Pathology,

University of Illinois, USA

Prof. Amitava Adhikary

Dept. of Physical Chemistry, Radiation Chemistry of Biomolecules

Oakland University, USA

Dr. Surendra Shukla

Department of Oncology Science

OU Health Stephenson Cancer Center, USA

Prof. Ajit K Saxena

Prof & HOD, Dept. of Pathology and Lab Medicine,

AIIMS, INDIA

Prof. Sebastian Schoppmann

Head, Upper-GI-Service, Dept. of General Surgery

Medical University of Vienna, AUSTRIA

Dr. Hemant Sarin

Senior Cancer Researcher

USA

Prof. Vaibhav Sahai

Dept. of Medical Oncology, Hematology,

University of Michigan Health, USA

Dr. André Goy

Chairman and Chief Oncologist

John Theurer Cancer Center, USA

Prof. Ibrahim El Bayoumy

Professor,

Tanta Faculty of Medicine, EGYPT

Prof. Pooja Jain

Professor, Department of Microbiology and Immunology

Drexel University College of Medicine, USA

Prof. Dipali Sharma

Professor, Dept. of Oncology

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, USA

Prof. Divij Verma

Dept. of Oncology

Albert Einstein College of Medicine, USA

Prof. Bhagavatula Moorthy

Professor, Dept. of Pediatrics

Baylor College of Medicine, USA




SCIENTIFIC SESSION

  • Track 1: Bladder Cancer
  • Track 2: Bone Cancer
  • Track 3: Brain Cancer
  • Track 4: Breast Cancer
  • Track 5: Cancer Genetics & Genomics
  • Track 6: Cancer Immunotherapy & Vaccines
  • Track 7: Cancer Metabolism
  • Track 8: Cell Signalling & Regulation
  • Track 9: Cell-Based Therapy
  • Track 10: Chemical Biology
  • Track 11: Chronic Myeloid Leukemia
  • Track 12: Chronic Lymphocytic Leukemia
  • Track 13: Developmental Biology
  • Track 14: Endocrine Cancer
  • Track 15: Epidemiology
  • Track 16: Epigenetics
  • Track 17: Exercises Oncology
  • Track 18: Imaging
  • Track 19: Immunology
  • Track 20: Lung Cancer
  • Track 21: Lymphoma
  • Track 22: Palliative Care
  • Track 23: Genome Integrity
  • Track 24: Gynecologic Cancer
  • Track 25: Microbiome & Inflammation
  • Track 26: Molecular Pathology & Diagnostics
  • Track 27: Multiple Myeloma
  • Track 28: Nanotechnology
  • Track 29: Neuroscience & Neuro-Oncology
  • Track 30: Renal Cell Carcinoma
  • Track 31: Sarcoma
  • Track 32: Skin Cancer
  • Track 33: Side Effect Management
  • Track 34: Solid Tumor Oncogenesis
  • Track 35: Stem Cells
  • Track 36: Structural Biology
  • Track 37: Systems Biology
  • Track 38: Targeted Therapy
  • Track 39: Tumor Micro Environment
  • Track 40: Urologic Cancers
  • Track 41: Pancreatic Cancer
  • Track 42: Pediatric Cancer
  • Track 43: Prostate Cancer
  • Track 44: Gastrointestinal Cancer
  • Track 45: Head & Neck Cancer
  • Track 46: Hematologic Malignancies
  • Track 47: HPV & Cervical Cancer
  • Track 48: Metastasis & Drug Resistance



SUBMIT ABSTRACT

Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days. Submission implies the intent of at least one author to register, attend the symposium and present the paper orally or in poster format. Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance.
  • The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
  • The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
  • Do not use bold type or underline formatting. Italic type is acceptable.
  • Text may be in multiple paragraphs.
  • Any references should be noted as citations within the text and not as footnotes at the end
Important Dates
2nd Phase Abstract Submission had been Extended till: 15th January, 2024
Early Bird Registration Closes: 27th February, 2023
Click Here to Submit Abstract
Click Here to Download Brochure



ORGANIZING & SCIENTIFIC COMMITTEE

Padma Shri Dr. Lalit Kumar

Prof & HOD, Dept of Medical Oncology,

AIIMS, INDIA

Padma Shri Dr. Ashok Gupta

Senior Plastic Surgeon,

BHIMS, INDIA

Padma Shri Dr. Ramakant K. Deshpande

Senior Oncologist & Director,

Asian Cancer Institute, INDIA

Dr. G. K. Rath

Chief-Radiation Oncologist,

AIIMS, INDIA

Dr. Shekhar C Mande

Former Director General, CSIR

National President, Vijnana Bharati

Shri Praveen Ramdas

Secretary

Vijnana Bharati, INDIA

Prof. Rajeev Singh

Secretary,

Indraprastha Vigyan Bharati, INDIA

Dr. Raghavendra Rao

Director-CCRYN,

Ministry of AYUSH, INDIA

Dr. Shyam Aggarwal

Senior Medical Oncologist,

Sir Ganga Ram Hospital, INDIA

Dr. Ashok Sharma

Additional Professor,

AIIMS/NCI-Jhajjar, INDIA

Dr. Tarang Krishna

Director,

Cancer Healer Center, INDIA

Dr. Deepika Krishna

Director,

Cancer Healer Center, INDIA


PAST SPONSORS

8th World Cancer Congress - 2023 | New Delhi 8th World Cancer Congress - 2023 | New Delhi

SUPPORTING JOURNALS
8th World Cancer Congress - 2023 | New Delhi

CONTACT US AT

Conference Secretariat
UNITED STATES
ARJYOPA HEALTHCARE
16192 Coastal Hwy., Lewes, DE 19958, US


INDIA
ARJYOPA HEALTHCARE
#2 RBC Road, Dumdum
Kolkata - 700028, West Bengal, India
Ph: +91 7002-412-271

WRITE TO US




8th World Cancer Congress - 2023 | New Delhi

PHOTO GALLERY(OUR PAST EVENTS)
8th World Cancer Congress - 2023 | New Delhi
ORGANISED BY

8th World Cancer Congress - 2023 | New Delhi 7th World Cancer Congress - 2022 | Bangalore